{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Anaheim",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "83711",
      "recalling_firm": "Preferred Pharmaceuticals, Inc",
      "address_1": "1250 N Lakeview Ave Ste O",
      "address_2": "",
      "postal_code": "92807-1801",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Product was distributed to 1 physician in Gainesville  Florida.",
      "recall_number": "D-1877-2019",
      "product_description": "Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09",
      "product_quantity": "79 (90 ct.) bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20190829",
      "center_classification_date": "20190924",
      "termination_date": "20230424",
      "report_date": "20191002",
      "code_info": "Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021",
      "more_code_info": ""
    }
  ]
}